Health Catalyst (NASDAQ:HCAT – Free Report) had its target price lowered by Canaccord Genuity Group from $12.00 to $11.00 in a report issued on Friday morning, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other brokerages have also weighed in on HCAT. Stifel Nicolaus dropped their price objective on […]
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) insider Linda Llewelyn sold 3,163 shares of the firm’s stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $10.83, for a total transaction of $34,255.29. Following the completion of the transaction, the insider now owns 68,048 shares […]
Health Catalyst (NASDAQ:HCAT – Get Free Report) was upgraded by investment analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a report issued on Monday, Briefing.com reports. The brokerage presently has a $11.00 price objective on the stock, down from their prior price objective of $12.00. Piper Sandler’s target price would […]
Shares of Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) have received an average rating of “Moderate Buy” from the nine ratings firms that are presently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month […]
Cantor Fitzgerald reaffirmed their overweight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $16.00 target price on the stock. Separately, Canaccord Genuity Group reduced their price target on shares of Health Catalyst from $16.00 to $14.00 and […]